Advances in understanding the pathogenesis of familial thrombocythaemia
- 8 February 2011
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 152 (6) , 701-712
Abstract
Summary: Familial thrombocytosis can be divided into two broad categories. The first includes inherited syndromes that affect only the megakaryocytic lineage with Mendelian inheritance, high penetrance and polyclonal haematopoiesis. The second category includes inherited predisposition to true Philadelphia‐negative myeloproliferative neoplasms (MPN) and is characterized by low penetrance, clonal haematopoiesis and presence of somatic mutations such as JAK2 V617F. It must be underlined that these two categories represent two well separate entities, with different patterns of proliferation and different transmission modalities. This review will focus on the molecular pathogenesis of hereditary thrombocytosis, underlining those clinical pictures that are specifically associated with mutations in the genes of thrombopoietin or in its receptor. Moreover, we propose an approach for the diagnosis and therapy of these syndromes.Keywords
This publication has 91 references indexed in Scilit:
- Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasmsBlood, 2010
- MegakaryopoiesisSeminars in Hematology, 2010
- Ubiquitination and degradation of the thrombopoietin receptor c-MplBlood, 2010
- Ligand-independent Thrombopoietin Mutant Receptor Requires Cell Surface Localization for Endogenous ActivityJournal of Biological Chemistry, 2009
- Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24 577 first-degree relatives of 11 039 patients with myeloproliferative neoplasms in SwedenBlood, 2008
- Transcriptional regulation of bone marrow thrombopoietin by platelet proteinsExperimental Hematology, 2008
- New thrombopoietic growth factorsBlood, 2007
- JAK2Exon 12 Mutations in Polycythemia Vera and Idiopathic ErythrocytosisNew England Journal of Medicine, 2007
- MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid MetaplasiaPLOS Medicine, 2006
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005